Avalo Therapeutics Inc AVTX Valuation Ratios and Share Stats

S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Avalo Therapeutics Inc (AVTX)
Avalo Therapeutics Inc (AVTX) Financials

Avalo Therapeutics Inc (AVTX)

11.50

-0.91

(-7.33%)

Closed 19 November 8:00AM

Delayed by 15 minutes

11.50

0.00

( 0.00% )

Pre Market: 11:05PM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-120.115	48.555	-70.656	-30.594	-159.02	-136.124	-73.354	-116.056
Return on Equity (%)	-247.867	84.583	-164.259	-77.654	-278.766	-354.194	-684.77	1747.106
Return on Invested Capital (%)	-206.405	88.481	-104.395	-67.494	-361.423	-203.252	-130.941	-487.75
Operating Margin (%)	-1388.378	49.833	-214.301	-236.889	-1002.791	-1521.934	-207.523	-1461.175
Net Profit Margin (%)	-1428.621	42.678	-218.546	-241.037	-947.903	-1563.097	-230.779	-1639.501
Book Value Per Share	0.022	-0.131	-0.655	0.094	0.114	0.077	-2.685	-0.017
Earnings Per Share	-1.746	0.38	-0.982	-0.367	-0.847	-0.748	-4.417	-0.164
Cash Per Share	0.544	0.079	0.261	0.081	0.252	0.484	1.397	0.039
Working Capital Per Share	0.143	-0.013	-0.105	-0.047	0.144	0.372	-0.604	0.02
Operating Profit Per Share	0.122	0.883	0.266	0.168	0.087	0.036	1.563	0.004
EBIT Per Share	-1.746	0.443	-0.982	-0.36	-0.896	-0.75	-4.414	-0.164
EBITDA Per Share	-1.746	0.443	-0.982	-0.36	-0.896	-0.75	-4.414	-0.164
Free Cash Flow Per Share	-1.745	0.367	-1.079	-0.394	-0.87	-0.762	-4.425	-0.164

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	9.43M	31.27M	40.8M	44.38M	75M	112.79M	9.43M	N/A

Key Stats and Ratios

Year End 31 December 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	9.41M	9.43M	N/A	14.04M	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	-1894.316	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	-2095.789	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	119.53M
Price to Earnings Ratio	-0.97
Price to Sales Ratio	15.83
Price to Cash Ratio	4.11
Price to Book Ratio	4.17
Dividend Yield	-

Share Statistics

Shares Outstanding	10.39M
Average Volume (1 week)	101.66k
Average Volume (1 Month)	68.02k
52 Week Change	-46.52%
52 Week High	34.46
52 Week Low	3.9501

More Ratios Coming Soon!

Avalo Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions